Guildford, UK – MedPharm Ltd., a renowned leader in contract development and manufacturing organization (CDMO) services specializing in topical and transdermal product design, is thrilled to announce a significant enhancement to its leadership structure. Patrick Walsh, a distinguished figure in the CDMO sector and Operating Partner at Ampersand Capital Partners, steps in as the new Executive Chairman of MedPharm Ltd. The board also welcomes Minor Hinson, representing Bourne Partners Strategic Capital, as a new member. These appointments underscore MedPharm’s commitment to steering the company into its next growth phase with seasoned expertise and innovative strategies.
Lynn Allen, CEO of MedPharm, expressed enthusiasm about the new additions, stating, “The inclusion of Pat and Minor to the Board brings a wealth of experience and a track record of success that will be invaluable as we aim to accelerate MedPharm’s growth further. Their proven strategies and deep industry insights are perfectly aligned with our vision for the future.”
Patrick Walsh is recognized for his leadership roles across the healthcare and CDMO landscapes, including his tenure as CEO of Avista Pharma Solutions. His appointment follows a strategic investment by Ampersand Capital Partners in MedPharm, reflecting a strengthened partnership aimed at fostering growth and innovation.
Minor Hinson brings a rich background in healthcare investment and strategic growth initiatives, backed by his affiliation with Bourne Partners Strategic Capital. His expertise is expected to complement MedPharm’s strategic endeavors, especially in navigating the complexities of the global pharmaceutical landscape.
This strategic realignment with industry stalwarts like Walsh and Hinson joining the board is part of MedPharm’s broader initiative to cement its leadership in the pharmaceutical development sector. MedPharm, known for its proprietary, industry-leading performance testing models, continues to set benchmarks in the development of dermatology, nail, mucosal membrane, and transdermal products.
About MedPharm
